Additional file 1 of Supplemental oxygen therapy use among patients with fibrosing interstitial lung disease in the United States

Institutions

Publication Details

Journal
Figshare
Published
2025-01-01
DOI
https://doi.org/10.6084/m9.figshare.28517075.v1
Primary Topic
Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Additional file 1 of Supplemental oxygen therapy use among patients with fibrosing interstitial lung disease in the United States

Figshare
Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
article

Additional file 1 of Supplemental oxygen therapy use among patients with fibrosing interstitial lung disease in the United States

article en

Abstract

No abstract available for this paper.
Figshare
Optum (United States) (US), Optimum Therapeutics (United States) (US), Boehringer Ingelheim (United States) (US), Vanderbilt University Medical Center (US)
Good health and well-being
Openalex Percentile: Top 36%
Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
DOISourceOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Additional file 1 of Supplemental oxygen therapy use among patients with fibrosing interstitial lung disease in the United States · Figshare (2025) | TGRS Research Map | TGRS